Heterologous DNA-prime/protein-boost immunization with a monomeric SARS-CoV-2 spike antigen redundantizes the trimeric receptor-binding domain structure to induce neutralizing antibodies in old mice.
SARS-CoV-2
antibody response
antigen conformation
old mice
spike antigen
vaccination regimens
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2023
2023
Historique:
received:
30
05
2023
accepted:
09
08
2023
medline:
28
9
2023
pubmed:
27
9
2023
entrez:
27
9
2023
Statut:
epublish
Résumé
A multitude of alterations in the old immune system impair its functional integrity. Closely related, older individuals show, for example, a reduced responsiveness to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccines. However, systematic strategies to specifically improve the efficacy of vaccines in the old are missing or limited to simple approaches like increasing the antigen concentration or injection frequencies. We here asked whether the intrinsic, trimeric structure of the SARS-CoV-2 spike (S) antigen and/or a DNA- or protein-based antigen delivery platform affects priming of functional antibody responses particularly in old mice. The used S-antigens were primarily defined by the presence/absence of the membrane-anchoring TM domain and the closely interlinked formation/non-formation of a trimeric structure of the receptor binding domain (S-RBD). Among others, we generated vectors expressing prefusion-stabilized, cell-associated (TM
Identifiants
pubmed: 37753087
doi: 10.3389/fimmu.2023.1231274
pmc: PMC10518615
doi:
Substances chimiques
Antibodies, Neutralizing
0
Vaccines, DNA
0
Blood Group Antigens
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1231274Informations de copyright
Copyright © 2023 Pflumm, Seidel, Klein, Groß, Krutzke, Kochanek, Kroschel, Münch, Stifter and Schirmbeck.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Aging Cell. 2013 Apr;12(2):303-11
pubmed: 23410004
Anal Bioanal Chem. 2022 May;414(12):3561-3569
pubmed: 35260938
J Biomed Sci. 2022 Jun 9;29(1):37
pubmed: 35681239
N Engl J Med. 2020 Dec 17;383(25):2427-2438
pubmed: 32991794
Nat Rev Immunol. 2009 Mar;9(3):185-94
pubmed: 19240757
Nat Commun. 2022 Aug 8;13(1):4615
pubmed: 35941158
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Nature. 2021 Aug;596(7872):417-422
pubmed: 34192737
Front Immunol. 2022 Jun 10;13:898520
pubmed: 35757743
Vaccine. 2010 Apr 9;28(17):2999-3007
pubmed: 20170767
Vaccines (Basel). 2021 Mar 29;9(4):
pubmed: 33805473
Lancet Infect Dis. 2022 Nov;22(11):1565-1576
pubmed: 35963274
Front Immunol. 2021 Apr 28;12:647934
pubmed: 33995366
FASEB J. 2002 Jul;16(9):1108-10
pubmed: 12039856
Science. 2021 Aug 13;373(6556):
pubmed: 34210892
Vaccine. 2006 Jul 17;24(29-30):5655-69
pubmed: 16781023
Cell. 2022 Feb 3;185(3):447-456.e11
pubmed: 35026151
Front Immunol. 2022 Jul 25;13:882918
pubmed: 35958601
Lancet. 2022 Apr 2;399(10332):1313-1321
pubmed: 35367003
Biomedicines. 2022 Aug 17;10(8):
pubmed: 36009544
J Exp Med. 2004 Dec 20;200(12):1613-22
pubmed: 15611289
Blood. 2011 Aug 4;118(5):1294-304
pubmed: 21562046
Vaccines (Basel). 2021 Jul 03;9(7):
pubmed: 34358150
Cell. 2021 Apr 29;184(9):2384-2393.e12
pubmed: 33794143
Sci Immunol. 2020 Jun 11;5(48):
pubmed: 32527802
iScience. 2022 Dec 22;25(12):105479
pubmed: 36338436
Immun Ageing. 2023 Jan 17;20(1):4
pubmed: 36650551
EBioMedicine. 2022 Jan;75:103761
pubmed: 34929493
ACS Pharmacol Transl Sci. 2023 Feb 27;6(3):334-354
pubmed: 36923110
Sci Rep. 2018 Oct 2;8(1):14660
pubmed: 30279478
Annu Rev Virol. 2016 Sep 29;3(1):237-261
pubmed: 27578435
J Am Chem Soc. 2021 Jun 16;143(23):8543-8546
pubmed: 34086443
MedComm (2020). 2023 Mar 10;4(2):e238
pubmed: 36911160
Front Immunol. 2023 Mar 03;14:1113156
pubmed: 36936964
Nature. 2021 Dec;600(7890):701-706
pubmed: 34673755
Nature. 2020 Oct;586(7830):572-577
pubmed: 32726802
Nat Commun. 2021 Jan 11;12(1):244
pubmed: 33431842
Membranes (Basel). 2020 Aug 30;10(9):
pubmed: 32872641
Nat Commun. 2023 Mar 15;14(1):1451
pubmed: 36922492
BMJ. 2021 Feb 22;372:n188
pubmed: 33619170
Viral Immunol. 2013 Apr;26(2):126-32
pubmed: 23573979
Curr Opin Immunol. 2009 Jun;21(3):346-51
pubmed: 19500964
Front Immunol. 2021 Oct 05;12:733566
pubmed: 34675924
Nat Aging. 2021 Sep;1(9):769-782
pubmed: 34746804
Hum Vaccin Immunother. 2014;10(7):1985-92
pubmed: 25424808
Science. 2020 Sep 18;369(6510):1501-1505
pubmed: 32703906
N Engl J Med. 2022 Mar 17;386(11):1046-1057
pubmed: 35081293
mBio. 2021 Jun 29;12(3):e0122921
pubmed: 34182775
Front Immunol. 2019 Feb 27;10:318
pubmed: 30873171
Lancet. 2021 Sep 4;398(10303):856-869
pubmed: 34370971
J Mol Med (Berl). 2008 Sep;86(9):1067-79
pubmed: 18551265
Stem Cell Res. 2020 Dec 15;50:102125
pubmed: 33341604
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15053-8
pubmed: 14657384
Front Immunol. 2020 Oct 07;11:576622
pubmed: 33117378
Front Immunol. 2022 May 27;13:890517
pubmed: 35711466
J Biotechnol. 2021 Jan 20;326:21-27
pubmed: 33301853
Vaccine. 2008 Jul 23;26(31):3947-57
pubmed: 18724414
Vaccine. 2009 Jul 16;27(33):4388-401
pubmed: 19450632
Vaccines (Basel). 2023 May 09;11(5):
pubmed: 37243067
J Gen Virol. 2017 Aug;98(8):2143-2155
pubmed: 28758637
Emerg Microbes Infect. 2021 Dec;10(1):833-841
pubmed: 33853515
J Exp Med. 2022 Dec 5;219(12):
pubmed: 36129445
mBio. 2021 Oct 26;12(5):e0181321
pubmed: 34634927
Front Immunol. 2021 Apr 22;12:660198
pubmed: 33968063
J Med Virol. 2023 Feb;95(2):e28584
pubmed: 36794675
Clin Infect Dis. 2008 Apr 1;46(7):1078-84
pubmed: 18444828
ACS Infect Dis. 2021 Aug 13;7(8):2546-2564
pubmed: 34260218
N Engl J Med. 2021 Sep 9;385(11):1049-1051
pubmed: 34260850
J Biol Chem. 2021 Jan-Jun;296:100759
pubmed: 33965375
Front Immunol. 2021 Jul 12;12:701501
pubmed: 34322129
Nat Commun. 2022 May 24;13(1):2891
pubmed: 35610270
Nature. 2021 Apr;592(7853):283-289
pubmed: 33524990
Nat Aging. 2022 Oct;2(10):896-905
pubmed: 37118289
Immun Ageing. 2020 Nov 19;17(1):37
pubmed: 33292323
Int J Mol Sci. 2022 Nov 08;23(22):
pubmed: 36430190
NPJ Vaccines. 2023 Jun 5;8(1):84
pubmed: 37271785
Nat Rev Microbiol. 2023 Mar;21(3):162-177
pubmed: 36653446
Cell. 2020 Nov 12;183(4):1024-1042.e21
pubmed: 32991844
Geroscience. 2020 Apr;42(2):505-514
pubmed: 32274617
Eur J Immunol. 1999 May;29(5):1740-9
pubmed: 10359129
Front Immunol. 2022 Apr 29;13:876037
pubmed: 35572536
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Nat Med. 2021 Sep;27(9):1525-1529
pubmed: 34262158
Nat Commun. 2021 Jan 14;12(1):372
pubmed: 33446655
Aging Cell. 2009 Feb;8(1):18-25
pubmed: 18986373
J Infect. 2023 Sep;87(3):230-241
pubmed: 37331429
Nat Microbiol. 2022 Feb;7(2):195-199
pubmed: 35013593
Nat Microbiol. 2022 Aug;7(8):1106-1107
pubmed: 35836001
J Virol. 2004 Oct;78(19):10328-35
pubmed: 15367599